Prices delayed by at least 15 minutes | Print
GSK plc (GSK)
ADROpen
$39.39
Previous close
$39.6
Trade high
$39.5
Volume
2,636,945
Year high
$43.84
Year low
$33.33
Dividend yield
3.7%
Market capitalisation
$80.23 bn
P/E ratio
13.27
ISIN
US37733W2044
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 17/11/2023 | 23/02/2024 |
| Ex-dividend date | 16/11/2023 | 22/02/2024 |
| Payment date | 11/01/2024 | 11/04/2024 |
| Amount | $0.356356 | $0.4060608 |
Company profile
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.